CAJ | 학술논문

目的：初步探讨临床上急性心肌梗死患者糖化血红蛋白含量与其疾病的预后之间的关系，为疾病的临床治疗提供参考。方法：对我院心内科2013年02月—2015年02月收治的106例急性心肌梗死患者临床资料进行回顾性分析，根据患者糖化血红蛋白含量的不同将其分成正常组（糖化血红蛋白＜6.0%）和偏高组（糖化血红蛋白≥6.0%），比较两组患者住院期间心源性休克及心力衰竭等症状的发生频率，并且通过NIHSS评分以及治疗后30 d改良情况的Rankin’s评分情况。结果：本研究统计结果表明，偏高组患者的心源性休克及心力衰竭的发生率高于正常组患者，差异极显著（P＜0.01）；偏高组患者的NIHSS评分及治疗后30 d改良情况的Rankin's评分高于正常组患者，两组差异显著（P＜0.05）。结论：本研究结果表明，急性心肌梗死患者的糖化血红蛋白含量升高会导致患者临床疾病的恶化，危害患者生命健康，使得患者疾病的预后不良，因此对于这类患者在临床治疗过程中采用必要措施控制糖化血红蛋白的含量具有十分重要的意义。
목적：초보탐토림상상급성심기경사환자당화혈홍단백함량여기질병적예후지간적관계，위질병적림상치료제공삼고。방법：대아원심내과2013년02월—2015년02월수치적106례급성심기경사환자림상자료진행회고성분석，근거환자당화혈홍단백함량적불동장기분성정상조（당화혈홍단백＜6.0%）화편고조（당화혈홍단백≥6.0%），비교량조환자주원기간심원성휴극급심력쇠갈등증상적발생빈솔，병차통과NIHSS평분이급치료후30 d개량정황적Rankin’s평분정황。결과：본연구통계결과표명，편고조환자적심원성휴극급심력쇠갈적발생솔고우정상조환자，차이겁현저（P＜0.01）；편고조환자적NIHSS평분급치료후30 d개량정황적Rankin's평분고우정상조환자，량조차이현저（P＜0.05）。결론：본연구결과표명，급성심기경사환자적당화혈홍단백함량승고회도치환자림상질병적악화，위해환자생명건강，사득환자질병적예후불량，인차대우저류환자재림상치료과정중채용필요조시공제당화혈홍단백적함량구유십분중요적의의。
Objective: To study the relationship between prognosis of acute myocardial infarction and glycated hemoglobin disorders in order to provide reference for clinical treatment of the disease. Methods: 106 cases of acute myocardial infarction treated in the Cardiology of our hospital from February 2013 to February 2015 were retrospectively analyzed and were randomly divided into normal group (glycated hemoglobin<6.0%) and high group (glycated hemoglobin≥6.0%),depending on the patient's glycated hemoglobin contents. We compared the incidence frequency of cardiogenic shock and heart failure of the two groups during hospitalization by NIHSS score and Rankin's score 30d improvement. Results: The statistical results showed that the high group had significantly higher incidence of cardiogenic shock and heart failure than the patients of the normal group (P<0.01);the high group had higher NIHSS score and Rankin’s scores of 30 d improvements than the normal group of patients, with significant difference (P<0.05).Conclusion:Increased glycated hemoglobin levels of patients with acute myocardial infarction can lead to a deterioration of disease, endangering the life and health of patients and then poor prognosis of the disease.Therefore it is necessary to adopt some measures to control the content of glycated hemoglobin for patients with these kinds of diseases.